A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

被引：1
|
作者：
Leiper, K
Woolner, JT
Parker, TJ
van der Vleit, M
Mullan, MM
Fear, S
Rhodes, JM
Hunter, JO
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Acad Hosp, Cambridge, England
[3] Roy Castle Int Ctr Lung Canc Res, Liverpool, Merseyside, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84470-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3032
引用
收藏
页码：A583 / A583
页数：1
相关论文
共 50 条
  • [1] A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease
    Leiper, K
    Woolner, J
    Mullan, MMC
    Parker, T
    van der Vleit, M
    Fear, S
    Rhodes, JM
    Hunter, JO
    GUT, 2001, 48 : A2 - A2
  • [2] A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease
    Leiper, K
    Woolner, J
    Mullan, MMC
    Parker, T
    van der Vliet, M
    Fear, S
    Rhodes, JM
    Hunter, JO
    GUT, 2001, 49 (06) : 790 - 794
  • [3] Randomised double-blind trial of polymeric versus elemental diet in treatment of active Crohn's disease
    Verma, S
    Brown, S
    Giaffer, MH
    GUT, 1997, 40 : W75 - W75
  • [4] Elemental versus polymeric diet in treatment of active Crohn's disease: A double-blind randomised trial
    Verma, S
    Brown, S
    Giaffer, MH
    GUT, 1997, 41 : A226 - A226
  • [5] Randomised double-blind placebo-controlled trial of recombinant humanised antibody to α4 integrin (Antegren™) in active Crohn's disease.
    Gordon, FH
    Lai, CWY
    Hamilton, MI
    Allison, MC
    Fouweather, M
    Donoghue, S
    Greenless, C
    Amlot, PL
    Srivastava, ED
    Subhani, J
    Pounder, RE
    GASTROENTEROLOGY, 1999, 116 (04) : A726 - A726
  • [6] Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease
    Benjamin, Jane L.
    Hedin, Charlotte R. H.
    Koutsoumpas, Andreas
    Ng, Siew C.
    McCarthy, Neil E.
    Hart, Ailsa L.
    Kamm, Michael A.
    Sanderson, Jeremy D.
    Knight, Stella C.
    Forbes, Alastair
    Stagg, Andrew J.
    Whelan, Kevin
    Lindsay, James O.
    GUT, 2011, 60 (07) : 923 - 929
  • [7] A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease
    Schoelmerich, Juergen
    Fellermann, Klaus
    Seibold, Frank W.
    Rogler, Gerhard
    Langhorst, Jost
    Howaldt, Stefanie
    Novacek, Gottfried
    Petersen, Andreas Munk
    Bachmann, Oliver
    Matthes, Harald
    Hesselbarth, Norbert
    Teich, Niels
    Wehkamp, Jan
    Klaus, Jochen
    Ott, Claudia
    Dilger, Karin
    Greinwald, Roland
    Mueller, Ralph
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 390 - 399
  • [8] Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
    Neurath, MF
    Wanitschke, R
    Peters, M
    Krummenauer, F
    zum Büschenfelde, KHM
    Schlaak, JF
    GASTROENTEROLOGY, 1998, 114 (04) : A1050 - A1050
  • [9] Rifabutin/streptomycin in the treatment of Crohn's disease. A double-blind controlled trial.
    Thayer, WR
    Reinert, SE
    Natarajan, R
    Szaro, J
    GASTROENTEROLOGY, 1996, 110 (04) : A1027 - A1027
  • [10] Randomised double-blind placebo-controlled trial of recombinant humanised antibody to alpha-4 integrin (Antegren) in active Crohn's disease.
    Gordon, FH
    Lai, CWY
    Hamilton, MI
    Allison, MC
    Fouweather, M
    Donoghue, S
    Greenlees, C
    Amlot, PL
    Srivastava, ED
    Subhani, J
    Pounder, RE
    GUT, 1999, 44 : A42 - A42
12345